Biodegradable polymer support containing bioactive material and manufacturing method therefor
US-2024299626-A1 · Sep 12, 2024 · US
US9561303B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9561303-B2 |
| Application number | US-201213543115-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 6, 2012 |
| Priority date | Jan 6, 2010 |
| Publication date | Feb 7, 2017 |
| Grant date | Feb 7, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A biocompatible composition for tissue repair or regeneration in mammals comprising one or more glass former compounds selected from the group consisting of B 2 O 3 , P 2 O 5 , and SiO 2 and director elements selected from the group consisting of Cu, Sr, Zn, Fe, Mn, Cr, V, Nb, Mo, W, Ba, Co, S, Al, Ti, Y, Mg, Si and/or Ni to promote in vivo calcium compound formation of calcium carbonate or other calcium compounds other than hydroxyapatite. Upon direct application of the biocompatible composition to a mammalian host, calcium carbonate or other calcium compounds other than hydroxyapatite form upon bioreaction of the composition with bodily fluids.
Opening claim text (preview).
The invention claimed is: 1. A biocompatible composition for tissue repair or regeneration in mammals comprising: 40 to 80 wt % B 2 O 3 ; 2.5 to 50 wt % CaO; one or more of MgO, SrO, and combinations thereof in a cumulative concentration of 5 to 40 wt %; one or more of Li 2 O, Na 2 O, K 2 O, Rb 2 O and combinations thereof; one or more director elements selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, S, V, and/or Y in a cumulative concentration between 0.05 and 5 wt % to promote in vivo calcium compound formation of calcium carbonate or other calcium-containing materials other than hydroxyapatite; wherein upon direct application of the biocompatible composition to a mammalian host, calcium carbonate or other calcium-containing materials other than hydroxyapatite form upon bioreaction of the composition with bodily fluids; wherein the composition is in a form of one or more of fibers, hollow fibers, tubes, ribbons, solid spheres, hollow spheres, particles, bonded particles, and combinations thereof assembled in a scaffold which has a porosity of between about 15 and about 90 vol % with at least about 75 vol % of pores being interconnected and suitable for application to a mammalian host such that it is exposed to the mammalian host's bodily fluids for tissue repair or regeneration in mammals; and wherein the composition is not water soluble. 2. The biocompatible composition of claim 1 wherein said calcium carbonate or other calcium-containing materials other than hydroxyapatite that forms upon bioreaction of the composition with bodily fluids comprises calcite; and wherein hydroxyapatite also forms upon bioreaction of the composition with bodily fluids. 3. The biocompatible composition of claim 1 wherein hydroxyapatite does not form upon bioreaction of the composition with bodily fluids. 4. The biocompatible composition of claim 3 wherein the director element is selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, and/or S. 5. The biocompatible composition of claim 3 wherein the director element is selected from the group consisting of Cu, Mn, Ba, Co, and/or S. 6. The biocompatible composition of claim 3 wherein the director element is Zn and/or Fe. 7. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 said one or more director elements; said one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F. 8. The biocompatible composition of claim 1 consisting of approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 and said one or more director elements, one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F. 9. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 12 to 24 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO. 10. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO. 11. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO 0.1 to 2.5 wt % ZnO. 12. The biocompatible composition of claim 1 comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 0.1 to 2.5 wt % CuO 0.1 to 2.5 wt % ZnO 0.1 to 2.5 wt % Fe 2 O 3 wherein the one or more director elements is supplied by said CuO, ZnO, and/or Fe 2 O 3 . 13. A biocompatible composition for tissue repair or regeneration in mammals comprising, approximately: 40 to 80 wt % B 2 O 3 1 to 25 wt % Na 2 O 1 to 25% K 2 O 5 to 40 wt % CaO 1 to 25 wt % MgO 1 to 10 wt % P 2 O 5 one or more director elements selected from the group consisting of Cu, Zn, Fe, Mn, Ba, Co, S, V, and/or Y in a cumulative concentration between 0.05 and 5 wt % to promote in vivo calcium compound formation of calcium carbonate or other calcium-containing materials other than hydroxyapatite; optionally one or more of Li 2 O, Rb 2 O, SiO 2 , Al 2 O 3 , and F; wherein the composition is in the form of a scaffold of glass fibers; wherein the scaffold has a porosity of between about 15 and about 90 vol % with at least about 75 vol % of pores being interconnected; wherein the glass fibers have lengths between about 2 and about 150 mm and a length:diameter aspect ratio of at least 5:1; wherein the composition is not water soluble. 14. The biocompatible composition of claim 3 wherein the composition comprises from 10 to 90 wt % of components having one composition and from 10 to 90 wt % of components of a different composition. 15. The biocompatible composition of claim 3 wherein the composition is in the form of fibers and spheres. 16. The biocompatible composition of claim 1 wherein the one or more director elements are Zn and Fe. 17. The biocompatible composition of claim 1 wherein the one or more director elements is Zn. 18. The biocompatible composition of claim 1 wherein the one or more director elements is Fe. 19. The composition of claim 1 comprising fibers having a diameter between 20 and 5000 microns. 20. The composition of claim 1 comprising fibers having a diameter between 100 and 300 microns. 21. The composition of claim 1 comprising particles having a particle size in the range of 150 to 300 microns.
Ceramics or glasses · CPC title
Materials at least partially resorbable by the body · CPC title
Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.